Retatrutide, an experimental weight loss drug, has demonstrated an average weight loss of 26.6% over 84 weeks in clinical trials. Unlike standard GLP-1 medications that target one hormone, Retatrutide targets three separate hormones to curb hunger and regulate blood sugar, making it the strongest jab available.
How Retatrutide Differs From Standard ‘Fat Jabs’
Most popular weight loss injections, known as GLP-1 agonists, mimic a single hormone to signal the brain that the body is full after eating. This process reduces cravings and controls blood sugar levels.
Retatrutide operates on a triple-hormone mechanism. According to clinical trial data, this triple-action approach led to the 26.6% weight loss figure.
Case Study: Dizzll TV’s Four-Week Experiment
YouTuber Dizzll TV (@DizzllTV) documented a self-administered trial of Retatrutide to track its impact on his health and physique. Over a four-week period using a one-milligram dosage, he reported an 11-pound weight loss, bringing his total weight to 274.6 lbs.
Dizzll attributed the results to a combination of the peptide and a strict lifestyle regimen, which included a fitness routine and a daily intake of around ‘900-ish’ calories. He described the weight loss as “amazing” and “shocking.”
The physical changes were reflected in his body composition data:
- Starting Body Fat: Approximately 31.2%
- Ending Body Fat: 28% to 29%
- Weekly Average Loss: Almost 3 lbs per week
Dizzll noted that he experienced few struggles or side effects during his short-term use, though he emphasized that his results were paired with significant caloric restriction.
Health Risks and Regulatory Warnings
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued warnings regarding the use of these drugs outside of supervised clinical settings. The agency notes several suspected side effects, including nausea and sickness.
Medical authorities warn that purchasing experimental peptides from unverified sources poses risks to your health. Because Retatrutide is not yet commercially approved, it is only approved for clinical trials.
Comparison of Weight Loss Mechanisms
| Feature | Standard GLP-1 Jabs | Retatrutide (Experimental) |
|---|---|---|
| Hormone Targets | Single Hormone | Three Hormones |
| Clinical Avg. Loss | Varies by drug | 26.6% over 84 weeks |
| Availability | Prescription/Commercial | Clinical Trials Only |
Frequently Asked Questions
Is Retatrutide legal to buy?
No, it is currently only approved for use within official clinical trials. The MHRA warns against procuring it illegally.
How much weight can you lose on Retatrutide?
In clinical trials, participants saw an average weight loss of 26.6% over 84 weeks. Individual results vary, as seen in the case of Dizzll TV, who lost 11 lbs in four weeks.
What are the side effects?
According to the MHRA, suspected side effects include nausea and sickness. There are additional risks associated with purchasing it outside of its clinical trials.
What are your thoughts on the rise of triple-hormone weight loss drugs? Do you think they will replace traditional GLP-1s? Let us know in the comments below or subscribe to our newsletter for the latest medical breakthroughs.